Human Molecular Genetics Advance Access published online on August 22, 2007
Human Molecular Genetics, doi:10.1093/hmg/ddm218
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Restoration of the Balanced
/ß-globin Gene Expression in ß654–Thalassemia Mice using combined RNAi and Antisense RNA Approach

Shanghai Institute of Medical Genetics, Shanghai Children's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, P. R. China
* To whom correspondence should be addressed at: 24/1400 West Beijing Road, Shanghai Institute of Medical Genetics, Shanghai Children's Hospital, Shanghai 200040, China. Telephone: (8621)62790545, Fax: (8621)62475476, E-Mail: ytzeng{at}stn.sh.cn
Received June 5, 2007; Revised August 4, 2007; Accepted August 4, 2007
ß-thalassemia is associated with abnormality in ß-globin gene, leading to imbalanced synthesis of
-/ß-globin chains. Consequently, the excessive free
-globin chains precipitate to the erythrocyte membrane, resulting in hemolytic anemia. We have explored post-transcriptional strategies aiming at
-globin reduction and ß-globin enrichment on ß654 (Hbbth-4/Hbb+) mouse, carrying a human splicing-deficient ß-globin allele (Hbbth-4). Lentiviral vectors of short hairpin RNA (shRNA) targeting
-globin and/or antisense RNA facilitating ß-globin correct splicing were microinjected into ß654 single-cell embryos. Three transgenic strains were generated, as
i-Hbbth-4/Hbb+(shRNA), ßa-Hbbth-4/Hbb+(antisense) and
ißa-Hbbth-4/Hbb+(both shRNA and antisense ). Without notable abnormalities, all the founders and their offsprings showed sustained amelioration of hematologic parameters, ineffective erythropoiesis, and extramedullary hematopoiesis. Augmented effects appeared in
ißa-Hbbth-4/Hbb+, which correlated with a better-balanced
-/ß-globin mRNA level. Among the transgenic mice integrated with shRNA and antisense RNA, one homozygous mouse (Hbbth-4/Hbbth-4) had been viable, and the 3-week survival rate for heterozygotes (Hbbth-4/Hbb+) was 97%, comparing to 45.4% of untreated. Our data have demonstrated the feasibility of techniques for ß-thalassemia therapy by balancing the synthesis of
-/ß-globin chains.
Present address: Binzhou Medical College, Binzhou, ShanDong Province, China
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
E. van de Vosse, E. M. Verhard, R. A. de Paus, G. J. Platenburg, J. C. T. van Deutekom, A. Aartsma-Rus, and J. T. van Dissel Antisense-mediated exon skipping to correct IL-12R{beta}1 deficiency in T cells Blood, May 7, 2009; 113(19): 4548 - 4555. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. P. J. Voon and J. Vadolas Controlling {alpha}-globin: a review of {alpha}-globin expression and its impact on {beta}-thalassemia Haematologica, December 1, 2008; 93(12): 1868 - 1876. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. P. J. Voon, H. Wardan, and J. Vadolas siRNA-mediated reduction of {alpha}-globin results in phenotypic improvements in {beta}-thalassemic cells Haematologica, August 1, 2008; 93(8): 1238 - 1242. [Abstract] [Full Text] [PDF] |
||||

